Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 46 to 60 of 87 results for hepatitis c

  1. NICE recommended that clinical data, including genotype and sustained virological response at 12 weeks, is collected for all people treated with sofosbuvir in the NHS.

    details Comes from guidance Sofosbuvir for treating chronic hepatitis C Number TA330 Date issued February 2015 Other

    Research recommendation
    Published
    9 June 2015

  2. NICE recommended that clinical data, including genotype and sustained virological response at 12 weeks, are collected for all people having treatment with simeprevir in the NHS.

    clinical data from people having treatment with the new generation of hepatitis C virus treatments. NICE agreed that such efforts should...

    Research recommendation
    Published
    9 June 2015

  3. What cost-effective interventions can be used to increase hepatitis B case-finding among migrant populations in primary and secondary care?

    Question What cost-effective interventions can be used to increase hepatitis B case-finding among migrant populations in primary and...

    Research recommendation
    Published
    9 June 2015

  4. What cost-effective interventions ensure continuity of care for prisoners who are diagnosed with chronic hepatitis B or C in prison?

    ensure continuity of care for prisoners who are diagnosed with chronic hepatitis B or C in prison? Any explanatory notes(if...

    Research recommendation
    Published
    9 June 2015

  5. What are the most effective ways of involving people from groups at increased risk in awareness-raising about, and promoting testing and treatment for, hepatitis B and C infection? Specifically, how cost effective are peer mentor programmes at increasing the number of people at increased risk who are tested and treated for hepatitis B and C?

    awareness-raising about, and promoting testing and treatment for, hepatitis B and C infection? Specifically, how cost...

    Research recommendation
    Published
    9 June 2015

  6. What impact does increased knowledge and awareness of hepatitis B and C among the general public have on the uptake of testing and treatment?

    Question What impact does increased knowledge and awareness of hepatitis B and C among the general public have on the...

    Research recommendation
    Published
    9 June 2015

  7. Which interventions for other communicable diseases could be used to encourage people at increased risk of hepatitis B and C infection to take up the offer of testing and treatment?

    communicable diseases could be used to encourage people at increased risk of hepatitis B and C infection to take up the...

    Research recommendation
    Published
    9 June 2015

  8. How can the uptake of hepatitis C treatment be improved? What factors influence whether or not specific groups at increased risk will begin and complete hepatitis C treatment?

    uptake of hepatitis C treatment be improved? What factors influence whether or not specific groups at increased risk will begin and...

    Research recommendation
    Published
    9 June 2015

  9. How can case-finding for hepatitis B and C be improved? What modifiable factors influence whether or not specific groups at increased risk of hepatitis B and hepatitis C infection are identified and tested?

    for hepatitis B and C be improved? What modifiable factors influence whether or not specific groups at increased risk of...

    Research recommendation
    Published
    9 June 2015

  10. How cost effective are alternative testing sites, such as community pharmacist programmes, for increasing the number of people who are tested and treated for hepatitis B and C?

    for hepatitis B and C? Any explanatory notes(if applicable) None. Source guidance details Comes from guidance...

    Research recommendation
    Published
    9 June 2015

  11. How cost effective are cohort testing programmes: - as a stand-alone programme, or - as an extension of the NHS Health Check programme?

    None. Source guidance details Comes from guidance Hepatitis B and C testing: people at risk of infection Number PH43 Date

    Research recommendation
    Published
    9 June 2015

  12. How many children in the UK are infected with chronic hepatitis B and C and which subgroups of the population do they come from?

    Question How many children in the UK are infected with chronic hepatitis B and C and which subgroups of the population do...

    Research recommendation
    Published
    9 June 2015

  13. How many people in the UK are infected with chronic hepatitis B and C and which subgroups of the population do they come from?

    Question How many people in the UK are infected with chronic hepatitis B and C and which subgroups of the population do...

    Research recommendation
    Published
    9 June 2015

  14. Introducing a blood borne virus testing facility within a substance misuse harm reduction service

    A project to introduce hepatitis and HIV blood borne virus testing in a needle exchange and drug treatment

    Shared learning
    Last updated
    16 April 2015

  15. The OraQuick HCV point‑of‑care test for rapid detection of hepatitis C virus antibodies (MIB24)

    NICE has developed a medtech innovation briefing (MIB) on the OraQuick HCV point-of-care test for rapid detection of hepatitis C virus antibodies

    Medtech innovation briefing
    Published
    2 March 2015